Innoviva Strategic Opportunities LLC is Director & 10% Owner at Armata Pharmaceuticals, Inc. (ARMP). They have made 5 open-market trades across 2 companies since 2021, most recently 2023-01-10.
CIK 0001842875
5 open-market purchases totalling $129.5M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ETTX | BUY | 2022-07-08 | 2022-07-13 | $2.20 | $84.8M | N/A | N/A | N/A |
| ARMP | BUY | 2022-02-09 | 2022-02-11 | $5.00 | $18.1M | -2.2% | -27.1% | -29.0% |
| ARMP | BUY | 2021-10-29 | 2021-11-01 | $3.30 | $8.0M | -14.0% | +22.6% | +23.6% |
| ETTX | BUY | 2021-06-11 | 2021-06-11 | $2.00 | $12.5M | -15.2% | -18.7% | -14.2% |
| ARMP | BUY | 2021-01-26 | 2021-01-28 | $3.25 | $6.1M | +23.3% | +9.9% | -14.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.